info@aelabgroup.com
QR Code 1
QR Code 2

Coagulation Analyzer

Introduction

A Coagulation Analyzer automates blood clotting tests to assess hemostasis quickly and accurately in clinical, research, and surgical settings. By standardizing PT, aPTT, INR, and related assays, a Coagulation Analyzer improves turnaround time, reduces operator error, and supports better therapeutic decisions.


What Is Coagulation Analyzer?

A coagulation analyzer is a laboratory instrument that evaluates the blood-clotting system (hemostasis) by introducing specific reagents to citrated plasma and measuring clot formation or factor activity. Common tests include Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), Fibrinogen, Thrombin Time (TT), D-dimer, and calculated INR, used to diagnose bleeding/thrombotic disorders and to monitor anticoagulant therapy.


Devices in This Category

  • Semi-automated coagulation analyzers (manual reagent add, low throughput)
  • Fully automated coagulation analyzers (walk-away, high throughput)
  • Photo-optical/photometric clot detection systems
  • Electromechanical coagulation analyzers
  • Chromogenic/immunologic analyzers for factor/D-dimer assays
  • Point-of-care INR/coag monitors (limited parameters)
  • Thromboelastography/rotational thromboelastometry devices (global clot dynamics)

Technical Features and Specifications

Feature Details
Core Tests PT, aPTT, Fibrinogen, TT, D-dimer, INR; optional factors (VIII/IX) & VWF (model-dependent)
Detection Methods Photo-optical turbidity, electromechanical, chromogenic substrates, immunologic latex assays
Throughput ~30–400 tests/hour (choose per workload)
Sample & Reagents 10–150 µL plasma/test; onboard reagent cooling and barcode ID on many systems
Reaction Conditions 37 °C controlled incubation with automated mixing/clot detection
Connectivity Touchscreen UI; LIS/host via HL7/ASTM; export PDF/CSV/XML; QC and audit trails
Maintenance & Safety Auto-clean cycles, clot/level alarms, disposable cuvettes, onboard QC rules
Sample Type 3.2% sodium-citrate plasma; pediatric low-volume options available on select models

Benefits

  • High accuracy and precision with standardized, automated workflows
  • Faster turnaround time—many results in <5 minutes
  • Reduced human error in timing, pipetting, and result calculation
  • Integrated QC supports compliance and accreditation readiness
  • Improved clinical decision-making for anticoagulant management and surgery

Applications and Tests

🔬 Molecular Biology

  • Research on coagulation pathways and factor activity
  • Drug discovery studies evaluating anticoagulant/antithrombotic effects
  • Assay development and validation for hemostasis biomarkers

🧪 Clinical Diagnostics

  • Hospital labs for routine PT/aPTT/INR and D-dimer testing
  • Anticoagulant therapy monitoring (warfarin, heparin, DOAC workflows*)
  • Pre-operative screening and ER/trauma coagulation assessment

🏭 Industrial & Food Testing

  • Pharmaceutical QC of hemostasis reagents and reference materials
  • CRO/biotech method transfers and inter-lab standardization
  • Device and reagent lot release testing for coagulation assays

🌱 Environmental & Agricultural Labs

  • Veterinary coagulation profiles for companion and livestock animals
  • Comparative physiology studies in academic/agricultural research
  • Biobanking/sample integrity checks for animal models

Coagulation Analyzer vs. Manual Testing

Aspect Coagulation Analyzer Manual Testing
Speed Very fast; automated timing and readout Time-consuming, operator-timed
Accuracy High; precise, reproducible Variable; user-dependent
Operator Dependence Minimal after setup High (pipetting/timing)
QC Integration Built-in QC rules and audit trails Limited/no integration
Long-Term Cost Cost-efficient via reduced repeats and labor Higher from repeats and variability
Standardization Strong inter-operator and inter-site consistency Challenging to standardize

Expert Tips for Choosing the Right Coagulation Analyzer

  • Match throughput (tests/hour) to current and projected sample volumes.
  • Verify reagent flexibility—open systems can reduce long-term costs.
  • Prioritize low sample volume capability for pediatric and neonatal work.
  • Confirm LIS integration (HL7/ASTM) and robust QC/audit features.
  • Plan scalability—modular analyzers and additional channels for growth.

Maintenance Best Practices

  • Run daily QC at appropriate levels; document per policy.
  • Perform scheduled calibration and reagent lot cross-over checks.
  • Use auto-clean cycles and replace cuvettes/tubing per IFU to prevent carryover.
  • Monitor reagent storage (onboard refrigeration/expiry) and barcode tracking.
  • Train staff regularly to prevent pre-analytical errors (mixing, citrate ratio, HCT impacts*).

FAQ

Q: What’s the difference between PT and aPTT?
A: PT evaluates the extrinsic/common pathways (e.g., warfarin), while aPTT assesses the intrinsic/common pathways (e.g., heparin response).

Q: How often should quality control be performed?
A: Daily QC is recommended—more frequently for high-volume or critical care testing—to ensure accuracy and compliance.

Q: Are coagulation analyzers suitable for point-of-care testing?
A: POC devices exist primarily for INR/warfarin monitoring and offer limited parameters compared with full laboratory analyzers.

Q: What sample type is required?
A: Use properly collected 3.2% sodium-citrate plasma; follow local guidelines for fill volume and processing to avoid pre-analytical errors.

Looking for specific lab equipment? Fill out the form below, and our team will get back to you with detailed information and a personalized quote.